Angiotensin ii alters aortic fibronectin independently of hypertension

Hideo Himeno, Dennis Crawford, Masayuki Hosoi, Aram V. Chobanian, Peter Brecher

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

We performed these studies to assess the potential role of hemodynamic forces in mediating the changes in aortic fibronectin mRNA expression that occur in the rat in response to angiotensin II administration. With the use of an acute hypertensive model involving a 3-day infusion with a pressor dose of angiotensin II given by osmotic minipump, a selective increase in fibronectin mRNA expression but not of several other extracellular matrix genes was documented. This change was inhibited by losartan, indicating the importance of angiotensin receptors in the response. Prazosin, hydralazine, or L-arginine added to the drinking water all lowered the angiotensin II-induced increase in blood pressure but did not attenuate the increase in fibronectin mRNA expression. Angiotensin- converting enzyme inhibition using trandolapril did reduce fibronectin mRNA in the angiotensin H-infusion model, despite an inability to reduce blood pressure, whereas when angiotensin I was infused, quinapril lowered both blood pressure and fibronectin expression even at doses that did not completely normalize blood pressure. These studies suggest that angiotensin II induced an increase in aortic fibronectin mRNA that was not dependent solely on blood pressure.

Original languageEnglish (US)
Pages (from-to)823-826
Number of pages4
JournalHypertension
Volume23
Issue number6
StatePublished - 1994
Externally publishedYes

Fingerprint

Angiotensins
Fibronectins
Hypertension
Angiotensin II
Blood Pressure
Messenger RNA
trandolapril
Hydralazine
Angiotensin I
Angiotensin Receptors
Losartan
Prazosin
Peptidyl-Dipeptidase A
Drinking Water
Extracellular Matrix
Arginine
Hemodynamics
Genes

Keywords

  • Angiotensin II
  • Aorta
  • Experimental
  • Extracellular matrix
  • Fibronectins
  • Hypertension

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Himeno, H., Crawford, D., Hosoi, M., Chobanian, A. V., & Brecher, P. (1994). Angiotensin ii alters aortic fibronectin independently of hypertension. Hypertension, 23(6), 823-826.

Angiotensin ii alters aortic fibronectin independently of hypertension. / Himeno, Hideo; Crawford, Dennis; Hosoi, Masayuki; Chobanian, Aram V.; Brecher, Peter.

In: Hypertension, Vol. 23, No. 6, 1994, p. 823-826.

Research output: Contribution to journalArticle

Himeno, H, Crawford, D, Hosoi, M, Chobanian, AV & Brecher, P 1994, 'Angiotensin ii alters aortic fibronectin independently of hypertension', Hypertension, vol. 23, no. 6, pp. 823-826.
Himeno H, Crawford D, Hosoi M, Chobanian AV, Brecher P. Angiotensin ii alters aortic fibronectin independently of hypertension. Hypertension. 1994;23(6):823-826.
Himeno, Hideo ; Crawford, Dennis ; Hosoi, Masayuki ; Chobanian, Aram V. ; Brecher, Peter. / Angiotensin ii alters aortic fibronectin independently of hypertension. In: Hypertension. 1994 ; Vol. 23, No. 6. pp. 823-826.
@article{bf8b7d8a2b1a4e4389f541bd797694ac,
title = "Angiotensin ii alters aortic fibronectin independently of hypertension",
abstract = "We performed these studies to assess the potential role of hemodynamic forces in mediating the changes in aortic fibronectin mRNA expression that occur in the rat in response to angiotensin II administration. With the use of an acute hypertensive model involving a 3-day infusion with a pressor dose of angiotensin II given by osmotic minipump, a selective increase in fibronectin mRNA expression but not of several other extracellular matrix genes was documented. This change was inhibited by losartan, indicating the importance of angiotensin receptors in the response. Prazosin, hydralazine, or L-arginine added to the drinking water all lowered the angiotensin II-induced increase in blood pressure but did not attenuate the increase in fibronectin mRNA expression. Angiotensin- converting enzyme inhibition using trandolapril did reduce fibronectin mRNA in the angiotensin H-infusion model, despite an inability to reduce blood pressure, whereas when angiotensin I was infused, quinapril lowered both blood pressure and fibronectin expression even at doses that did not completely normalize blood pressure. These studies suggest that angiotensin II induced an increase in aortic fibronectin mRNA that was not dependent solely on blood pressure.",
keywords = "Angiotensin II, Aorta, Experimental, Extracellular matrix, Fibronectins, Hypertension",
author = "Hideo Himeno and Dennis Crawford and Masayuki Hosoi and Chobanian, {Aram V.} and Peter Brecher",
year = "1994",
language = "English (US)",
volume = "23",
pages = "823--826",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Angiotensin ii alters aortic fibronectin independently of hypertension

AU - Himeno, Hideo

AU - Crawford, Dennis

AU - Hosoi, Masayuki

AU - Chobanian, Aram V.

AU - Brecher, Peter

PY - 1994

Y1 - 1994

N2 - We performed these studies to assess the potential role of hemodynamic forces in mediating the changes in aortic fibronectin mRNA expression that occur in the rat in response to angiotensin II administration. With the use of an acute hypertensive model involving a 3-day infusion with a pressor dose of angiotensin II given by osmotic minipump, a selective increase in fibronectin mRNA expression but not of several other extracellular matrix genes was documented. This change was inhibited by losartan, indicating the importance of angiotensin receptors in the response. Prazosin, hydralazine, or L-arginine added to the drinking water all lowered the angiotensin II-induced increase in blood pressure but did not attenuate the increase in fibronectin mRNA expression. Angiotensin- converting enzyme inhibition using trandolapril did reduce fibronectin mRNA in the angiotensin H-infusion model, despite an inability to reduce blood pressure, whereas when angiotensin I was infused, quinapril lowered both blood pressure and fibronectin expression even at doses that did not completely normalize blood pressure. These studies suggest that angiotensin II induced an increase in aortic fibronectin mRNA that was not dependent solely on blood pressure.

AB - We performed these studies to assess the potential role of hemodynamic forces in mediating the changes in aortic fibronectin mRNA expression that occur in the rat in response to angiotensin II administration. With the use of an acute hypertensive model involving a 3-day infusion with a pressor dose of angiotensin II given by osmotic minipump, a selective increase in fibronectin mRNA expression but not of several other extracellular matrix genes was documented. This change was inhibited by losartan, indicating the importance of angiotensin receptors in the response. Prazosin, hydralazine, or L-arginine added to the drinking water all lowered the angiotensin II-induced increase in blood pressure but did not attenuate the increase in fibronectin mRNA expression. Angiotensin- converting enzyme inhibition using trandolapril did reduce fibronectin mRNA in the angiotensin H-infusion model, despite an inability to reduce blood pressure, whereas when angiotensin I was infused, quinapril lowered both blood pressure and fibronectin expression even at doses that did not completely normalize blood pressure. These studies suggest that angiotensin II induced an increase in aortic fibronectin mRNA that was not dependent solely on blood pressure.

KW - Angiotensin II

KW - Aorta

KW - Experimental

KW - Extracellular matrix

KW - Fibronectins

KW - Hypertension

UR - http://www.scopus.com/inward/record.url?scp=0028223429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028223429&partnerID=8YFLogxK

M3 - Article

C2 - 8206611

AN - SCOPUS:0028223429

VL - 23

SP - 823

EP - 826

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 6

ER -